INS specialists have issued an alert regarding the increase in cases of respiratory infections caused by influenza and other diseases. In response to this, the Ministry of Health (Minsa) is promoting vaccination for individuals under 5 years of age and over 60 years of age.
As winter sets in, the south and east regions of Peru are experiencing low temperatures, which has led to a rise in respiratory infections. Minsa emphasizes the importance of protecting children under 5 years of age, pregnant women, individuals with comorbidities, and those over 60 years of age against influenza and pneumococcus.
According to the Minsa vaccination schedule, infants receive their first dose of the influenza vaccine at 6 months of age, followed by a second dose at 7 months. The vaccine is then updated annually from the age of 1 to 5 years. Pregnant women can receive the vaccine at any gestational age. Individuals with comorbidities and those over 60 years of age should receive an annual dose, preferably between May and June.
In terms of the pneumococcal vaccine, minors receive their first dose at 2 months of age, followed by a second dose at 4 months, and a third dose at 1 year of age. Children between the ages of 2 and 4 who have not received any pneumococcal vaccine should receive a one-time dose. Individuals between the ages of 5 and 60 who have not received any dose and suffer from chronic lung disease, kidney disease, heart disease, diabetes, HIV infection, Down syndrome, neoplasia, or other comorbidities should receive the vaccine once in their lifetime. Those over 60 years of age and health personnel also require a dose of the vaccine against pneumococcus.
The Minsa Immunization Directorate reports that as of 2023, 24% of children under 5 years of age have been vaccinated against influenza, and 60% have been vaccinated against pneumococcus. Among individuals over 60 years of age, 31% have been protected against influenza, and 16.8% have been protected against pneumococcus. It is advised that individuals visit the nearest health facility to determine which vaccine is missing and receive the necessary immunization.
A recent study conducted by the National Institute of Health (INS) revealed that the influenza virus is the main cause of acute respiratory infection in the country this year. While the SARS-CoV-2 virus is still identified as a cause of acute respiratory infection, its prevalence has decreased compared to previous years. There has been an increase in respiratory syncytial virus (RSV) cases in recent weeks, particularly among children under 1 year of age. INS specialists recommend frequent hand washing and annual vaccination against influenza for at-risk groups to prevent the transmission of the virus.
The INS continues to conduct national surveillance and urges regions to send samples of Severe Acute Respiratory Infections (SARI) to identify their cause.
In addition to vaccination, the National Institute of Civil Defense (INDECI) provides recommendations for preventing respiratory problems during low temperatures. These include wearing warm clothing and suitable footwear, avoiding sudden temperature changes, protecting the head, face, nose, and mouth to prevent cold air from entering the lungs, ensuring sufficient ventilation in public transport, consuming fruits, vegetables, and foods that provide protein, energy, and heat, generating more body heat through physical exercises, and seeking medical assistance or contacting the nearest health center in case of respiratory problems or hypothermia.
For more updates, follow Minsa on their social media platforms including Facebook, Twitter, Instagram, and YouTube.
How is Minsa working to raise awareness about the importance of vaccination and what vaccination campaigns are they promoting in the affected regions?
Nfluenza, and 52% of individuals over 60 years of age have received the pneumococcal vaccine. However, there is still a significant portion of the population that remains unprotected.
Minsa is working to raise awareness about the importance of vaccination and is actively promoting vaccination campaigns in the affected regions. They are urging parents to ensure their children receive the necessary doses of the influenza and pneumococcal vaccines as per the vaccination schedule. Pregnant women, individuals with comorbidities, and those over 60 years of age are strongly encouraged to get vaccinated to protect themselves from respiratory infections.
It is crucial to note that the influenza virus and pneumococcus bacteria can cause severe illness and even death, especially in vulnerable populations. Vaccination is an effective measure to prevent the spread of these diseases and reduce the burden on healthcare systems.
Minsa advises individuals to consult their healthcare providers or local health authorities for more information on vaccination schedules and availability. It is essential to stay updated with the latest recommendations and take proactive steps to protect oneself and loved ones from respiratory infections during the winter season.
